I-MAB (IMAB)

1.75 -0.02 (-1.13%) USD  |  NASDAQ  |  May 17, 14:59
More

I-MAB Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for IMAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2022. Upgrade now.
Date Value
March 17, 2024 --
August 17, 2023 --
March 31, 2023 --
October 31, 2022 --
Date Value
August 30, 2022 --
July 20, 2022 --
May 27, 2022 --

Revenue Estimates for Next Quarter Range, Past 5 Years

--
Minimum
May 27 2022
--
Maximum
May 27 2022
--
Average
--
Median
May 27 2022

Revenue Estimates for Next Quarter Benchmarks

Summit Therapeutics Inc Upgrade
Verastem Inc Upgrade
CEL-SCI Corp Upgrade
AIM ImmunoTech Inc Upgrade
IGC Pharma Inc Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade